Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
Tuberculosis (TB) is the leading cause of death in the world from an infectious disease. Its etiologic agent, the Mycobacterium tuberculosis (Mtb), is a slow-growing bacterium that has coexisted in humans for thousands of years. According to the World Health Organization, 10.6 million new cases of T...
Saved in:
Main Authors: | Andrea Picchianti-Diamanti, Alessandra Aiello, Chiara De Lorenzo, Giovanni Battista Migliori, Delia Goletti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1494283/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
by: Alyssa Howren, et al.
Published: (2025-01-01) -
Health Disparities in Rheumatology in the United States
by: Wright GC, et al.
Published: (2025-01-01) -
Unstable psoriasis in the setting of psoriatic arthritis: A rare presentation
by: Roma Raj, et al.
Published: (2022-01-01) -
Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review
by: Natasha Cox, et al.
Published: (2025-01-01) -
Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis
by: Giacomo Cafaro, et al.
Published: (2025-01-01)